Cargando…

Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China

Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients. Methods: Clinical data from 253 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yinfeng, Zheng, Jie, Xu, Yue, Lv, Ji, Wu, Zizheng, Feng, Kai, Liu, Jiani, Yan, Weitao, Wei, Liguang, Zhao, Jiangman, Jiang, Lisha, Han, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666181/
https://www.ncbi.nlm.nih.gov/pubmed/38028594
http://dx.doi.org/10.3389/fgene.2023.1271710
_version_ 1785138985200254976
author Liu, Yinfeng
Zheng, Jie
Xu, Yue
Lv, Ji
Wu, Zizheng
Feng, Kai
Liu, Jiani
Yan, Weitao
Wei, Liguang
Zhao, Jiangman
Jiang, Lisha
Han, Meng
author_facet Liu, Yinfeng
Zheng, Jie
Xu, Yue
Lv, Ji
Wu, Zizheng
Feng, Kai
Liu, Jiani
Yan, Weitao
Wei, Liguang
Zhao, Jiangman
Jiang, Lisha
Han, Meng
author_sort Liu, Yinfeng
collection PubMed
description Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients. Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants’ impact on protein structure and function. Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 (15.6%), and BRCA2 (15.0%). ACMG classification identified 7% of patients harboring Pathogenic/Likely Pathogenic (P/LP) variants, with one case displaying a pathogenic BRCA1 mutation linked to triple-negative breast cancer (TNBC). Also identified were two pathogenic MUTYH variants, previously associated with colon cancer but increasingly implicated in breast cancer. Variants of uncertain significance (VUS) were identified in 112 patients, with PTEN c.C804A showing the highest frequency. The role of these variants in sporadic breast cancer oncogenesis was suggested. In-depth exploration of previously unreported variants led to the identification of three potential pathogenic variants: ATM c.C8573T, MSH3 c.A2723T, and CDKN1C c.C221T. Their predicted impact on protein structure and stability suggests a functional role in cancer development. Conclusion: This study reveals a comprehensive overview of the genetic variants landscape in Chinese breast cancer patients, highlighting the prevalence and potential implications of rare variants. We emphasize the value of comprehensive genomic profiling in breast cancer management and the necessity of continuous research into understanding the functional impacts of these variants.
format Online
Article
Text
id pubmed-10666181
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106661812023-11-09 Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China Liu, Yinfeng Zheng, Jie Xu, Yue Lv, Ji Wu, Zizheng Feng, Kai Liu, Jiani Yan, Weitao Wei, Liguang Zhao, Jiangman Jiang, Lisha Han, Meng Front Genet Genetics Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients. Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants’ impact on protein structure and function. Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 (15.6%), and BRCA2 (15.0%). ACMG classification identified 7% of patients harboring Pathogenic/Likely Pathogenic (P/LP) variants, with one case displaying a pathogenic BRCA1 mutation linked to triple-negative breast cancer (TNBC). Also identified were two pathogenic MUTYH variants, previously associated with colon cancer but increasingly implicated in breast cancer. Variants of uncertain significance (VUS) were identified in 112 patients, with PTEN c.C804A showing the highest frequency. The role of these variants in sporadic breast cancer oncogenesis was suggested. In-depth exploration of previously unreported variants led to the identification of three potential pathogenic variants: ATM c.C8573T, MSH3 c.A2723T, and CDKN1C c.C221T. Their predicted impact on protein structure and stability suggests a functional role in cancer development. Conclusion: This study reveals a comprehensive overview of the genetic variants landscape in Chinese breast cancer patients, highlighting the prevalence and potential implications of rare variants. We emphasize the value of comprehensive genomic profiling in breast cancer management and the necessity of continuous research into understanding the functional impacts of these variants. Frontiers Media S.A. 2023-11-09 /pmc/articles/PMC10666181/ /pubmed/38028594 http://dx.doi.org/10.3389/fgene.2023.1271710 Text en Copyright © 2023 Liu, Zheng, Xu, Lv, Wu, Feng, Liu, Yan, Wei, Zhao, Jiang and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Liu, Yinfeng
Zheng, Jie
Xu, Yue
Lv, Ji
Wu, Zizheng
Feng, Kai
Liu, Jiani
Yan, Weitao
Wei, Liguang
Zhao, Jiangman
Jiang, Lisha
Han, Meng
Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
title Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
title_full Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
title_fullStr Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
title_full_unstemmed Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
title_short Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
title_sort multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern china
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666181/
https://www.ncbi.nlm.nih.gov/pubmed/38028594
http://dx.doi.org/10.3389/fgene.2023.1271710
work_keys_str_mv AT liuyinfeng multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT zhengjie multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT xuyue multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT lvji multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT wuzizheng multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT fengkai multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT liujiani multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT yanweitao multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT weiliguang multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT zhaojiangman multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT jianglisha multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina
AT hanmeng multigenetestingpanelsrevealpathogenicvariantsinsporadicbreastcancerpatientsinnorthernchina